Delivery Order SPE2DB22D2006-SPE2DB24FV9VF
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,808.30 firm-fixed price delivery order is for the supply of 4,565,262,622 Erythromycin 250 mg tablets. The contract does not have a set-aside designation and has an ultimate completion date of July 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,721.42 firm fixed-price delivery order contract is for the supply of 100 units of Erythromycin 250 mg tablets. The contract has an ultimate completion date of July 2, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,562,539 Erythromycin 500 mg tablets. The fixed-price delivery order, valued at $2,994.60, has an ultimate completion date of October 20, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,110,392 units of Erythromycin 250 mg tablets. The $4,010.52 contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,969.92 firm fixed price delivery order is for the supply of 4564589786 - Erythromycin DR 250 mg Tablets in quantities of 30s. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $1,314.77, is for the delivery of 4,565,477,781 Erythromycin 250 mg tablets in quantities of 100s. The contract is a firm fixed-price Delivery Order with an ultimate completion date of August 19, 2024. Amerisourcebergen is a major pharmaceutical distributor and has been awarded multiple Indefinite Delivery Contracts...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,979.79 firm fixed price delivery order is for the supply of 4,567,675,485 tablets of 250 mg Erythromycin. The contract has an ultimate completion date of March 25, 2025 and was awarded on March 24, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a Delivery Order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,400.95, is for the supply of 4,567,629,642 units of the drug Erythromycin 250 mg Tablet. The contract is a Firm Fixed Price agreement, with a period of performance through March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of 4,565,040 units of Erythromycin 250 mg tablets to the U.S. Department of Defense (DoD) medical supply chain. The contract was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a firm fixed-price basis. The award, valued at $2,849.87, is a delivery order under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to...
- This federal contract award, valued at $12,348.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,564,452,073 units of Erythromycin 250 mg tablets in 100-count bottles. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV9VFDelivery Order
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of 4,564,402,633 tablets of Erythromycin 250 mg to the agency's facilities. The $6,560.40 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Amerisourcebergen Corporation. The contract has an ultimate completion date of April 26, 2024 and does not utilize any set-aside designations. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 4/25/24 |